Which of the following would the nurse emphasize when teaching the client and family about measures to prevent reinfection and the transmission of a parasitic infection to others?

Choice A rationale:

Antihelminthic therapy does not need to be administered cautiously in clients who have cardiac disease unless there are specific contraindications or drug interactions that would necessitate caution. The primary concern in these cases would be ensuring that the chosen antihelminthic drug does not interact adversely with the medications used to manage the client's cardiac condition.

Choice B rationale:

Antihelminthic therapy should be administered cautiously in clients with hepatic impairment. The liver plays a significant role in drug metabolism and elimination. Clients with hepatic impairment may have altered drug metabolism, which can affect the pharmacokinetics of antihelminthic drugs. Therefore, caution is needed to adjust the dosing and monitor for potential side effects in clients with compromised liver function.

Choice C rationale:

Clients with diabetes do not typically require cautious administration of antihelminthic therapy solely due to their diabetes. However, it is essential to consider potential drug interactions with antidiabetic medications that the client may be taking. The primary concern would be ensuring that the antihelminthic drug does not interfere with diabetes management.

Choice D rationale:

Clients with respiratory disorders do not necessarily require cautious administration of antihelminthic therapy based solely on their respiratory condition. However, it is crucial to consider potential drug interactions with medications used to manage the respiratory disorder. Antihelminthic drugs are primarily targeted at parasitic infections and may not directly impact respiratory conditions.